Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Rocket Pharmaceuticals Inc., 3 years.
Rocket Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Sep 22, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $68.29 | $239,015 |
| Sep 8, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Sep 8, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $75.46 | $264,110 |
| Aug 18, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Aug 18, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $75.82 | $265,370 |
| Jul 21, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Jul 21, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $80.59 | $282,065 |
| Jul 7, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Jul 7, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $86.62 | $303,170 |
| Jun 23, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Jun 23, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $79.51 | $278,285 |
| Jun 18, 2026 | Rocket Pharmaceuticals Inc. | Grant or award | +22,862 | — | — |
| Jun 9, 2026 | Cytokinetics Incorporated | Option exercise | +3,500 | $7.80 | $27,300 |
| Jun 9, 2026 | Cytokinetics Incorporated | Open-market sale | −3,500 | $67.98 | $237,930 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.